Kingworld Medicines Group Ltd. has announced a new compensation plan under its 2025 Share Award Scheme, which includes the grant of awarded shares to 19 connected persons within the company. The grant, fully exempt from reporting and shareholder approval requirements under Chapter 14A of the Hong Kong Listing Rules, is intended to align the interests of the grantees with the company's long-term success. The announcement was made by Chairman Zhao Li Sheng on July 4, 2025, in Hong Kong.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.